MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.

Díaz LA, Fuentes-López E, Ayares G, Idalsoaga F, Arnold J, Valverde MA, Perez D, Gómez J, Escarate R, Villalón A, Ramírez CA, Hernandez-Tejero M, Zhang W, Qian S, Simonetto DA, Ahn JC, Buryska S, Dunn W, Mehta H, Agrawal R, Cabezas J, García-Carrera I, Cuyàs B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de-la-Tijera F, Kulkarni AV, Rao PN, Salazar PG, Skladaný L, Bystrianska N, Clemente-Sanchez A, Villaseca-Gómez C, Haider T, Chacko KR, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Marciano S, Dirchwolf M, Vargas V, Jiménez C, Louvet A, García-Tsao G, Roblero JP, Abraldes JG, Shah VH, Kamath PS, Arrese M, Singal AK, Bataller R, Arab JP

Open source

DOI
10.1016/j.jhepr.2023.100727
Published
2023 Aug
Container
JHEP reports : innovation in hepatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jhepr.2023.100727,
  title = {MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.},
  author = {Díaz LA and Fuentes-López E and Ayares G and Idalsoaga F and Arnold J and Valverde MA and Perez D and Gómez J and Escarate R and Villalón A and Ramírez CA and Hernandez-Tejero M and Zhang W and Qian S and Simonetto DA and Ahn JC and Buryska S and Dunn W and Mehta H and Agrawal R and Cabezas J and García-Carrera I and Cuyàs B and Poca M and Soriano G and Sarin SK and Maiwall R and Jalal PK and Abdulsada S and Higuera-de-la-Tijera F and Kulkarni AV and Rao PN and Salazar PG and Skladaný L and Bystrianska N and Clemente-Sanchez A and Villaseca-Gómez C and Haider T and Chacko KR and Romero GA and Pollarsky FD and Restrepo JC and Castro-Sanchez S and Toro LG and Yaquich P and Mendizabal M and Garrido ML and Marciano S and Dirchwolf M and Vargas V and Jiménez C and Louvet A and García-Tsao G and Roblero JP and Abraldes JG and Shah VH and Kamath PS and Arrese M and Singal AK and Bataller R and Arab JP},
  year = {2023},
  journal = {JHEP reports : innovation in hepatology},
  doi = {10.1016/j.jhepr.2023.100727},
  url = {https://doi.org/10.1016/j.jhepr.2023.100727}
}

RIS

TY  - JOUR
TI  - MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.
AU  - Díaz LA
AU  - Fuentes-López E
AU  - Ayares G
AU  - Idalsoaga F
AU  - Arnold J
AU  - Valverde MA
AU  - Perez D
AU  - Gómez J
AU  - Escarate R
AU  - Villalón A
AU  - Ramírez CA
AU  - Hernandez-Tejero M
AU  - Zhang W
AU  - Qian S
AU  - Simonetto DA
AU  - Ahn JC
AU  - Buryska S
AU  - Dunn W
AU  - Mehta H
AU  - Agrawal R
AU  - Cabezas J
AU  - García-Carrera I
AU  - Cuyàs B
AU  - Poca M
AU  - Soriano G
AU  - Sarin SK
AU  - Maiwall R
AU  - Jalal PK
AU  - Abdulsada S
AU  - Higuera-de-la-Tijera F
AU  - Kulkarni AV
AU  - Rao PN
AU  - Salazar PG
AU  - Skladaný L
AU  - Bystrianska N
AU  - Clemente-Sanchez A
AU  - Villaseca-Gómez C
AU  - Haider T
AU  - Chacko KR
AU  - Romero GA
AU  - Pollarsky FD
AU  - Restrepo JC
AU  - Castro-Sanchez S
AU  - Toro LG
AU  - Yaquich P
AU  - Mendizabal M
AU  - Garrido ML
AU  - Marciano S
AU  - Dirchwolf M
AU  - Vargas V
AU  - Jiménez C
AU  - Louvet A
AU  - García-Tsao G
AU  - Roblero JP
AU  - Abraldes JG
AU  - Shah VH
AU  - Kamath PS
AU  - Arrese M
AU  - Singal AK
AU  - Bataller R
AU  - Arab JP
PY  - 2023
JO  - JHEP reports : innovation in hepatology
DO  - 10.1016/j.jhepr.2023.100727
UR  - https://doi.org/10.1016/j.jhepr.2023.100727
ER  -

APA

LA, D., E, F., G, A., F, I., J, A., MA, V., D, P., J, G., R, E., A, V., CA, R., M, H., W, Z., S, Q., DA, S., JC, A., S, B., W, D., H, M., R, A., J, C., I, G., B, C., M, P., G, S., SK, S., R, M., PK, J., S, A., F, H., AV, K., PN, R., PG, S., L, S., N, B., A, C., C, V., T, H., KR, C., GA, R., FD, P., JC, R., S, C., LG, T., P, Y., M, M., ML, G., S, M., M, D., V, V., C, J., A, L., G, G., JP, R., JG, A., VH, S., PS, K., M, A., AK, S., R, B., & JP, A. (2023). MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.. JHEP reports : innovation in hepatology. https://doi.org/10.1016/j.jhepr.2023.100727

Source records